Skip to main content
. 2024 Oct 15;17(10):346–359. doi: 10.62347/GQWP4029

Figure 6.

Figure 6

Kaplan-Meier analysis log-rank test. A. Comparison of overall survival (OS) between high and low expression levels of CD34 in naïve (left panel) and neobev (right panel). B. Comparison of OS between high and low expression levels of ERG in naïve (left panel: P=0.3862; log-rank test) and neobev (right panel: P=0.7516; log-rank test). C. Left panel: TCGA data set; comparison of OS between low and high expressions of ERG in GBM cohort (P=0.1201, log-rank test; P=0.067, Wilcoxon test). Right panel: CGGA data set; comparison of OS between low and high expressions of ERG in the glioma cohort (P=0.0498, log-rank test; P=0.0241, Wilcoxon test).